BTIG’s Jonathan Krinsky is bullish on AppLovin Corporation ( NASDAQ: APP ), Flutter Entertainment ( NYSE: FLUT ), DraftKings ...

BTIG raised the firm’s price target on Okta (OKTA) to $110 from $98 and keeps a Buy rating on the shares. Against a difficult earnings season ...

BTIG lowered the firm’s price target on Alexandria Real Estate (ARE) to $144 from $186 and keeps a Buy rating on the shares. The firm notes ...

Janux Therapeutics (NASDAQ:JANX – Free Report) had its price target upped by BTIG Research from $82.00 to $100.00 in a ...

Fintel reports that on December 2, 2024, BTIG initiated coverage of BrightView Holdings (NYSE:BV) with a Buy recommendation.

Fintel reports that on December 2, 2024, BTIG downgraded their outlook for AnaptysBio (NasdaqGS:ANAB) from Buy to Neutral.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 7.01% of ...

BTIG Research has recently resumed Blackstone Mortgage Trust Inc (BXMT) stock to Buy rating, as announced on July 19, 2024, according to Finviz. Earlier, on June 25, 2024, Wolfe Research had initiated ...

Zscaler (NASDAQ:ZS – Get Free Report) had its price objective upped by research analysts at BTIG Research from $205.00 to ...

Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 ...

Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (LSE:0H8T) from Neutral to Buy. There are 152 funds or institutions reporting positions in Aclaris ...